Form D — Aeovian Pharmaceuticals, Inc.
0000905148-25-004456 · filed Dec 22, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $54,999,996
- Reported amount sold
- $54,999,996
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aeovian Pharmaceuticals, Inc.
- CIK
- 1710088
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2930 Domingo Ave., Suite 145
Berkeley, California 94705 - Phone
- 510-961-1148
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Allison J. Hulme · Executive OfficerBerkeley, California Find on LinkedIn ↗
-
Micah Zajic · Executive OfficerBerkeley, California Find on LinkedIn ↗
-
William Greene · DirectorBerkeley, California Find on LinkedIn ↗
-
Justin Gover · DirectorBerkeley, California Find on LinkedIn ↗
-
Richard Gaster · DirectorBerkeley, California Find on LinkedIn ↗
-
Lars Ekman · DirectorBerkeley, California Find on LinkedIn ↗
-
Nils Regge · DirectorBerkeley, California Find on LinkedIn ↗
-
Themasap Khan · DirectorBerkeley, California Find on LinkedIn ↗
-
Youssef Bennani · DirectorBerkeley, California Find on LinkedIn ↗
-
John Kincaid · Executive OfficerBerkeley, California Find on LinkedIn ↗
-
Davis Ryman · Executive OfficerBerkeley, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗